| 000 | 01175 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515080257.0 | ||
| 264 | 0 | _c20080103 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0165-6147 | ||
| 024 | 7 |
_a10.1016/j.tips.2007.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWebster, Keith A | |
| 245 | 0 | 0 |
_aProgrammed death as a therapeutic target to reduce myocardial infarction. _h[electronic resource] |
| 260 |
_bTrends in pharmacological sciences _cSep 2007 |
||
| 300 |
_a492-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 |
_aMyocardial Infarction _xtherapy |
| 650 | 0 | 4 | _aPhosphodiesterase 5 Inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 773 | 0 |
_tTrends in pharmacological sciences _gvol. 28 _gno. 9 _gp. 492-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tips.2007.07.004 _zAvailable from publisher's website |
| 999 |
_c17224137 _d17224137 |
||